NATURAL ALTERNATIVES INTERNATIONAL INC Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- NATURAL ALTERNATIVES INTERNATIONAL INC treasury stock, value, acquired, cost method for the quarter ending 2026-03-31 was $82.00K, a 51.19% decline year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC treasury stock, value, acquired, cost method for the quarter ending 2025-12-31 was $0.00.
- NATURAL ALTERNATIVES INTERNATIONAL INC treasury stock, value, acquired, cost method for the quarter ending 2025-09-30 was $5.00K, a 37.50% decline year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC treasury stock, value, acquired, cost method for the quarter ending 2025-06-30 was $2.00K, a 50.00% decline year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC treasury stock, value, acquired, cost method for fiscal 2025 was $178.00K, a 19.46% decline from fiscal 2024.
- NATURAL ALTERNATIVES INTERNATIONAL INC treasury stock, value, acquired, cost method for fiscal 2024 was $221.00K, a 85.30% decline from fiscal 2023.
- NATURAL ALTERNATIVES INTERNATIONAL INC treasury stock, value, acquired, cost method for fiscal 2023 was $1.50M, a 72.69% decline from fiscal 2022.
- NATURAL ALTERNATIVES INTERNATIONAL INC treasury stock, value, acquired, cost method for fiscal 2022 was $5.50M, a 32.70% increase from fiscal 2021.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-03-31 | $82.00K 10-Q · filed 2026-05-19 | $89.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2025-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $175.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-12 | $175.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2025-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $178.00K 10-K · filed 2025-09-23 |
| 2025-03-31 | $168.00K 10-Q · filed 2026-05-19 | $180.00K derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $229.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $8.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $221.00K 10-K · filed 2025-09-23 |
| 2024-03-31 | $217.00K 10-Q · filed 2025-05-14 | |
| 2023-09-30 | $497.00K 10-Q · filed 2023-11-09 | $1.50M derived: sum of 4 quarters · filed 2024-09-27 |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | $1.50M 10-K · filed 2024-09-27 |
| 2023-03-31 | $444.00K 10-Q · filed 2024-05-14 | $1.90M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $562.00K 10-Q · filed 2024-02-13 | $4.03M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | $497.00K 10-Q · filed 2022-11-09 | $5.99M derived: sum of 4 quarters · filed 2023-09-21 |
| 2022-06-30 | $398.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-21 | $5.50M 10-K · filed 2023-09-21 |
| 2022-03-31 | $2.57M 10-Q · filed 2023-05-15 | $5.11M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $2.53M 10-Q · filed 2023-02-08 | $3.18M derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-09-30 | $10.00K 10-Q · filed 2022-11-09 | $2.41M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-21 | $4.15M 10-K · filed 2022-09-21 |
| 2021-03-31 | $639.00K 10-Q · filed 2022-05-13 | $4.41M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $1.76M 10-Q · filed 2022-02-09 | $5.92M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | $1.74M 10-Q · filed 2021-11-09 | $5.47M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-20 | $3.75M 10-K · filed 2021-09-20 |
| 2020-03-31 | $2.15M 10-Q · filed 2021-05-13 | $3.91M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $1.32M 10-Q · filed 2021-02-09 | $2.27M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-09-30 | $15.00K 10-Q · filed 2020-11-10 | $1.38M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $426.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-21 | $1.37M 10-K · filed 2020-09-21 |
| 2019-03-31 | $511.00K 10-Q · filed 2020-05-14 | $946.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $424.00K 10-Q · filed 2020-02-11 | $854.00K derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-09-30 | $6.00K 10-Q · filed 2019-11-14 | $508.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-24 | $510.00K 10-K · filed 2019-09-24 |
| 2018-03-31 | $419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | $872.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $78.00K 10-Q · filed 2019-02-12 | |
| 2017-09-30 | $8.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $367.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-19 | $712.00K 10-K · filed 2018-09-19 |
| 2016-06-30 | $319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-18 | $648.00K 10-K · filed 2017-09-18 |
| 2016-03-31 | $117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $1.47M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | $1.79M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-09-30 | $172.00K 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-19 | $2.02M 10-K · filed 2016-09-19 |
| 2015-03-31 | $437.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | |
| 2014-06-30 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-18 | $60.00K 10-K · filed 2015-09-18 |
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-12 | $130.00K derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | $12.00K 10-Q · filed 2014-02-12 | $134.00K derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-09-30 | $11.00K 10-Q · filed 2014-11-12 | $563.00K derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-06-30 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-25 | $703.00K 10-K · filed 2014-09-25 |
| 2013-03-31 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14 | |
| 2012-12-31 | $441.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-12 | |
| 2012-09-30 | $151.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $405.00K 10-K · filed 2013-09-19 | |
| 2011-06-30 | $426.00K 10-K · filed 2012-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |